Quick Answer
CYTOKINETICS INC reported Operating Income Loss of -$612.26 million for the year ending 2025.
- CYTOKINETICS INC showed a decrease of -14.2% in Operating Income Loss from 2024 to 2025.
- This data is from CYTOKINETICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), CYTOKINETICS INC's Operating Income Loss has declined by 2,446.3%.
- Historical annual values: Fiscal year 2025: -$612.26 million | Fiscal year 2024: -$536.25 million | Fiscal year 2023: -$496.21 million | Fiscal year 2022: -$324.20 million | Fiscal year 2021: -$186.31 million | Fiscal year 2020: -$93.94 million | Fiscal year 2019: -$98.87 million | Fiscal year 2018: -$88.92 million | Fiscal year 2017: -$113.40 million | Fiscal year 2016: $18.69 million | Fiscal year 2015: -$37.41 million | Fiscal year 2014: -$14.75 million | Fiscal year 2013: -$33.89 million | Fiscal year 2012: -$40.46 million | Fiscal year 2011: -$47.96 million | Fiscal year 2010: -$49.64 million | Fiscal year 2009: $26.10 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: